Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
KAPIL KAPOOR
🇮🇳
India
Country
🇮🇳
India
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Ziv-aflibercept Efficacy in Better Regulating AMD
Phase 2
Completed
Conditions
Wet Age-related Macular Degeneration
Wet Macular Degeneration
Interventions
Drug: Ziv-Aflibercept 25 MG/ML [Zaltrap]
Drug: Ranibizumab
Subscribe
First Posted Date
2018-02-06
Last Posted Date
2020-10-06
Lead Sponsor
Kapil Kapoor
Target Recruit Count
62
Registration Number
NCT03423823
Locations
🇺🇸
Wagner Macula & Retina Center, Virginia Beach, Virginia, United States
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy